Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Joseph Crowe, Jr., MD, is Director of the Breast Center at Cleveland Clinic and Director of Breast Services, Cleveland Clinic Health System and OB/GYN and Women's Health Institute. Board-certified in surgery, Dr. Crowe has over 25 years experience in treating breast disease. He has a longstanding interest in the use of minimally invasive techniques for diagnosis and treatment of breast disease, has pioneered the development of nipple-sparing mastectomy, and is co-recipient of the Lula Zapis Chair of Molecular and Genetic Translational Breast Cancer Research at Cleveland Clinic. He has published over 100 peer-reviewed papers in scientific journals.
He is a member of numerous surgical and oncology societies. Dr. Crowe is a graduate of Amherst College and Case Western Reserve University School of Medicine. He did his surgical residency at University Hospitals of Cleveland and his fellowship in surgical oncology at Memorial Sloan Kettering Cancer Center in New York.
He began the breast surgery fellowship at Cleveland Clinic and over the past 15 years has trained numerous breast surgeons who hold various academic and private practice positions both in the United States and abroad.
breast cancer and breast disease, breast diagnostics, breast diseases, breast surgical oncology, oncoplastic surgery
Innovations & Patents
Innovator Award, Cleveland Clinic Innovations, 2007
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 12/3/2012, Dr. Crowe has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.